698 related articles for article (PubMed ID: 21549113)
1. Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease.
Zaitone S; Hassan N; El-Orabi N; El-Awady el-S
Eur J Pharmacol; 2011 Jul; 662(1-3):70-7. PubMed ID: 21549113
[TBL] [Abstract][Full Text] [Related]
2. Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats.
Elshazly SM
Eur J Pharmacol; 2015 Feb; 748():123-32. PubMed ID: 25542756
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure.
Zaitone SA; Barakat BM; Bilasy SE; Fawzy MS; Abdelaziz EZ; Farag NE
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):587-600. PubMed ID: 25708949
[TBL] [Abstract][Full Text] [Related]
4. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model.
Yalniz M; Bahcecioglu IH; Kuzu N; Poyrazoglu OK; Bulmus O; Celebi S; Ustundag B; Ozercan IH; Sahin K
J Gastroenterol Hepatol; 2007 Nov; 22(11):2009-14. PubMed ID: 17914984
[TBL] [Abstract][Full Text] [Related]
5. Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats.
Pan M; Song YL; Xu JM; Gan HZ
J Pineal Res; 2006 Aug; 41(1):79-84. PubMed ID: 16842545
[TBL] [Abstract][Full Text] [Related]
6. Dynamic expression of hepatic thioredoxin mRNA in rats with non-alcoholic fatty liver disease.
Duan XY; Zhao HP; Fan JG
J Dig Dis; 2010 Apr; 11(2):94-100. PubMed ID: 20402835
[TBL] [Abstract][Full Text] [Related]
7. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
Hong XZ; Li LD; Wu LM
Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
[TBL] [Abstract][Full Text] [Related]
8. Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study.
Heeba GH; El-Deen RM; Abdel-Latif RG; Khalifa MMA
Can J Physiol Pharmacol; 2020 Aug; 98(8):498-505. PubMed ID: 32083947
[TBL] [Abstract][Full Text] [Related]
9. Melatonin improves metabolic syndrome induced by high fructose intake in rats.
Kitagawa A; Ohta Y; Ohashi K
J Pineal Res; 2012 May; 52(4):403-13. PubMed ID: 22220562
[TBL] [Abstract][Full Text] [Related]
10. Ameliorative effect of melatonin against gamma-irradiation-induced oxidative stress and tissue injury.
El-Missiry MA; Fayed TA; El-Sawy MR; El-Sayed AA
Ecotoxicol Environ Saf; 2007 Feb; 66(2):278-86. PubMed ID: 16793135
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats.
Zhao JS; Zhu FS; Liu S; Yang CQ; Chen XM
Chin Med J (Engl); 2012 Jul; 125(13):2316-21. PubMed ID: 22882855
[TBL] [Abstract][Full Text] [Related]
12. Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-α and SREBP-1c.
Zhang J; Tan Y; Yao F; Zhang Q
Mol Med Rep; 2012 Oct; 6(4):815-20. PubMed ID: 22858825
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.
Samy W; Hassanian MA
Arab J Gastroenterol; 2011 Jun; 12(2):80-5. PubMed ID: 21684478
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease.
Hong X; Tang H; Wu L; Li L
J Pharm Pharmacol; 2006 Oct; 58(10):1391-8. PubMed ID: 17034663
[TBL] [Abstract][Full Text] [Related]
15. Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.
Xu P; Zhang XG; Li YM; Yu CH; Xu L; Xu GY
J Zhejiang Univ Sci B; 2006 Aug; 7(8):627-33. PubMed ID: 16845716
[TBL] [Abstract][Full Text] [Related]
16. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
Abd El-Haleim EA; Bahgat AK; Saleh S
Eur J Pharmacol; 2016 Feb; 773():59-70. PubMed ID: 26825546
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of phosphodiesterase 3, 4, and 5 inhibitors in amelioration of high-fat diet-induced nonalcoholic fatty liver in rats.
El-Deen RM; Heeba GH; Abdel-Latif RG; Khalifa MMA
Fundam Clin Pharmacol; 2020 Jun; 34(3):353-364. PubMed ID: 31885103
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
Zhang DM; Zhang GY; Wang T; Zhong HJ; Chen WK
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1279-83. PubMed ID: 16796890
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
Kawaguchi K; Sakaida I; Tsuchiya M; Omori K; Takami T; Okita K
Biochem Biophys Res Commun; 2004 Feb; 315(1):187-95. PubMed ID: 15013444
[TBL] [Abstract][Full Text] [Related]
20. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
